Alex Gasik

Alex Gasik is a Senior Director at Vertex Pharmaceuticals, leading the Global Value & Access Strategy team for non-CF pipeline therapies. With previous experience at Biogen and Simon-Kucher & Partners, Alex has expertise in market access, pricing, and HEOR activities for various therapeutic areas. With an MBA from Babson F.W. Olin Graduate School of Business, Alex brings a strong background in business strategy and market research to the table.